• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-05-26

  Anlotinib hydrochloride is a potent multi-target tyrosine kinase inhibitor with nanomolar efficacy against VEGFR2, PDGFRβ, and FGFR1. It demonstrates strong anti-angiogenic activity and favorable pharmacokinetics for cancer research. APExBIO's C8688 formulation offers validated selectivity and workflow reproducibility.

• Vardenafil HCl Trihydrate: Precision Tools for PDE5 Isoform

  2026-05-26

  Explore how Vardenafil HCl Trihydrate empowers researchers to dissect PDE5 isoform selectivity and proteoform-specific interactions, advancing cGMP signaling pathway studies. This article offers a unique, in-depth perspective on using Vardenafil in native proteomics and assay design.

• SAR405: Decoding Vps34 Inhibition for Selective Autophagy Co

  2026-05-25

  Explore how SAR405, a potent Vps34 inhibitor, enables precise autophagy inhibition and vesicle trafficking studies. This article uniquely bridges mechanistic insights with practical assay design, integrating new paradigms from recent AMPK research.

• Cy3 NHS ester (non-sulfonated): Technical Guide for Biomolec

  2026-05-25

  Cy3 NHS ester (non-sulfonated) enables precise fluorescent labeling of proteins, peptides, and oligonucleotides by targeting primary amines. It is best applied where robust, organic-solvent-compatible labeling is required and is not suitable for workflows that demand strict aqueous-only conditions or for labeling delicate proteins without a co-solvent.

• Anti-Fibrotic Action of 1-Phenyl-2-Pentanol in Hepatic Stell

  2026-05-24

  This study identifies 1-phenyl-2-pentanol, isolated from Moringa oleifera, as a potent inhibitor of hepatic stellate cell activation through dual modulation of TGF-β1 and Wnt/β-catenin pathways. The findings provide mechanistic insight into anti-fibrotic therapy development and inform experimental modeling of liver fibrosis.

• Structural Insights into Nipah Virus Polymerase Complex Asse

  2026-05-23

  The reference study delivers high-resolution structures of the Nipah virus L-P polymerase complex, uncovering the molecular organization and interactions essential for viral RNA synthesis. These findings provide a crucial foundation for structure-based antiviral development targeting henipavirus replication machinery.

• SAR405: Redefining Vps34 Inhibition for Autophagy Research

  2026-05-22

  Explore how SAR405, a highly selective Vps34 inhibitor, enables unprecedented precision in dissecting autophagy and vesicle trafficking. This article delivers new scientific depth and protocol guidance, building on recent discoveries in AMPK-ULK1-Vps34 signaling.

• Beyond Disulfide Reduction: Advanced Roles of TCEP Hydrochlo

  2026-05-22

  Explore how Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is redefining protein modification and assay sensitivity, with a deep dive into its mechanistic impact on modern biochemical workflows. Learn why APExBIO’s TCEP hydrochloride is pivotal for advanced protein analysis and innovative capture-and-release strategies.

• HOBt (1-Hydroxybenzotriazole) in Peptide Synthesis Workflows

  2026-05-21

  HOBt (1-Hydroxybenzotriazole) streamlines amide bond formation by minimizing epimerization and boosting coupling efficiency, critical for high-fidelity peptide and antibiotic derivative synthesis. This article details workflow enhancements, troubleshooting, and practical tips for maximizing HOBt’s impact, drawing from both literature and cutting-edge applied research.

• Molnupiravir Blocks Bourbon Virus Pathology in Mice Models

  2026-05-21

  This study demonstrates that molnupiravir, a broad-spectrum antiviral, effectively inhibits Bourbon virus replication and prevents lethal disease in a mouse model. The findings advance understanding of nucleoside analogue efficacy against emerging tick-borne RNA viruses and highlight avenues for translational antiviral research.

• CB-5083: Precision Disruption of Protein Homeostasis in Onco

  2026-05-20

  Explore how CB-5083, a potent p97 inhibitor, enables next-level oncology research by precisely disrupting protein homeostasis. This article uniquely integrates structural, mechanistic, and translational insights while guiding practical assay design.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-05-20

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide used for efficient amide bond formation in peptide synthesis and bioconjugation protocols. It is designed for controlled, in vitro applications and is not validated for in vivo or clinical workflows.

• AMPK Suppresses ULK1-Driven Autophagy: New Paradigms in Ener

  2026-05-19

  This study overturns the prevailing view that AMPK activates autophagy during glucose starvation, revealing instead that AMPK inhibits ULK1 and thus restrains autophagy induction. The findings reshape our understanding of cellular energy stress responses, with implications for experimental design in autophagy and vesicle trafficking research.

• Applied Workflows for Plerixafor (AMD3100) in CXCR4 Pathway

  2026-05-19

  Plerixafor (AMD3100) empowers researchers to dissect the CXCL12/CXCR4 axis with precision, enhancing studies in cancer metastasis inhibition, hematopoietic stem cell mobilization, and immunology. This article delivers actionable experimental workflows, troubleshooting insights, and comparative evidence to maximize reproducibility and translational impact using APExBIO's Plerixafor.

• AMPK Revisited: Suppression of Autophagy Under Energy Stress

  2026-05-18

  This study overturns the long-held view that AMPK directly stimulates autophagy during energy stress, revealing instead that AMPK suppresses autophagy initiation via inhibition of ULK1. The findings reshape our understanding of energy-sensing pathways and provide guidance for designing experiments probing the AMPK-ULK1-Vps34 axis.

16012 records 1/1068 page Next 12345 下5页 Last page